How NRIs Apply to Indian IPOs: The Repatriable vs Non-Repatriable Split, the UPI Limit Residents Take for Granted, and the US/Canada Wall

A reader in Toronto tried to apply to a large mainboard IPO last December through his Indian broker and the application simply would not submit. He assumed the app was broken. It was not. His KYC address sat in Canada, and the issue's prospectus carried a selling restriction that excluded persons in the United States and Canada, so the broker had quietly disabled IPO applications for his account. Separately, a reader in Dubai applied successfully but used UPI the way his cousin in Pune does, only to find no UPI mandate ever arrived on his NRE account, his bid lapsed, and he missed an allotment he would have flipped for a clean listing gain. Both problems were avoidable, and both come from the same root: the IPO machinery in India was built for residents, and NRIs are bolted on at the edges.

The 30-second answer: NRIs apply to Indian IPOs through ASBA, where the bank blocks the bid amount in your NRE (repatriable, blue form, NRI category) or NRO (non-repatriable, treated like a resident bid) account. You do not need a PIS account to apply; the primary market is a non-PIS route. UPI rarely works on NRE/NRO accounts in practice, so net-banking ASBA is the reliable path. The total NRI quota in an issue is capped at 10% (raisable to 24%), with 5% per individual. US and Canada NRIs are excluded from most issues by prospectus selling restrictions, so check the RHP. Listing gains sold within 12 months are short-term, taxed at 20% plus surcharge and cess under Section 115AD, with TDS deducted at source.

This guide assumes you already know what NRE and NRO accounts are and have a working NRI demat setup; if not, read the NRI demat account setup guide and the NRE, NRO and FCNR accounts guide first. What follows is the part nobody explains cleanly: which form and account decide whether your money can leave India again, why the UPI shortcut you keep hearing about almost certainly will not work for you, where the US and Canada wall actually sits, and what the tax really is when you flip the allotment on listing day.

The blue form versus the white form is the whole game

Every other decision in an NRI IPO application flows from one choice you make at the start: are you applying on a repatriation basis or not. This is not a tax election or a paperwork formality. It permanently determines whether the sale proceeds, years later, can be sent back to your country of residence.

Apply on a repatriation basis and you fund the bid from your NRE account. In the old physical-form world this was the blue application form reserved for non-residents bidding repatriably, and the colour language survives in broker interfaces and bank portals even though almost everything is electronic now. Shares allotted this way are held in a repatriable demat account, and when you eventually sell, the full proceeds (principal and gain, net of tax) can leave India.

Apply on a non-repatriation basis and you fund from your NRO account. This was the white form, the same one residents use, because a non-repatriable NRI bid is treated for quota and processing purposes much like a resident bid. Shares sit in a non-repatriable demat account, and the proceeds are subject to the USD 1 million per financial year repatriation ceiling that governs all NRO money, not free repatriation.

Here is the trap that costs people years of locked-up capital: the two demat accounts are separate, and you must apply through the one that matches the funding account. If you bid repatriably from your NRE account but the broker routes the allotment into your non-repatriable demat, you have created an instant mismatch that your bank and broker will spend weeks untangling, and in the worst case the bid is rejected at allotment. Before you ever click apply, confirm three things line up: the bank account (NRE or NRO), the demat account (repatriable or non-repatriable), and the bid basis selected in the broker's IPO screen. A resident never thinks about this because a resident has one of everything. You have two of everything, and the system does not always pair them for you.

A second, quieter rule: you bid from one PAN, so you pick one route per issue. Both your NRE and NRO accounts are mapped to the same PAN, and an IPO permits one application per PAN in the retail category. You cannot apply once repatriably and once non-repatriably to double your shot at allotment. Pick the basis that matches what you intend to do with the money, not the one you think improves your odds.

You do not need PIS to apply, but you may need it to sell

One of the most persistent confusions among NRIs is whether the Portfolio Investment Scheme stands between them and an IPO. It does not. IPO applications are explicitly outside PIS. The primary market is a non-PIS route: you apply through ASBA, the bank blocks the money, and no RBI PIS permission, designated PIS branch, or PIS reporting is involved at the application stage. An NRI who has never opened a PIS account can apply to an IPO today.

The nuance that bites later is the exit. PIS governs secondary-market transactions, the buying and selling of already-listed shares on the exchange. The moment your IPO shares list and you decide to sell, that sale is a secondary-market trade. What happens next depends on the basis you applied under.

If you applied non-repatriably from your NRO account, you can generally sell the listed shares through an ordinary NRO trading and demat setup on a non-PIS, non-repatriable basis, the same way the broader 2018 framework lets NRIs trade on a non-repatriation basis without PIS. If you applied repatriably from your NRE account and you want the sale proceeds to remain repatriable, the cleaner path is to route the sale through a PIS account so the repatriable character of the money is preserved and reported correctly. The full mechanics of the two routes, and why most NRIs now skip PIS for non-repatriable trading, are in buying Indian stocks under PIS.

The practical instruction is simple: apply non-PIS, but have your selling setup decided before allotment. If you are chasing a listing-day flip on a repatriable bid, you do not want to discover on listing morning that your repatriable selling pipe is not in place. Sort the demat, trading and PIS arrangement in the week you apply, not the week you sell.

Why the UPI shortcut almost certainly will not work for you

This is the single most common operational surprise, so be clear-eyed about it. When a resident applies to an IPO today, the default path is UPI: the broker submits the bid, a mandate request lands in the resident's UPI app, they approve it with a PIN, and the amount is blocked. It is fast, it works from a phone, and it has all but replaced net-banking ASBA for residents.

SEBI does permit NRI retail bidders to apply through UPI, and that line gets quoted everywhere. The problem is the gap between permitted and plumbed. The UPI-on-IPO rails were built around resident savings accounts, and the IPO-mandate flow specifically was never uniformly enabled on NRE and NRO accounts. UPI on NRI accounts has been rolling out for ordinary payments since 2024, with ICICI, HDFC, Axis, SBI, IDFC FIRST and others now supporting UPI through international mobile numbers from a list of countries including the US, UK, UAE, Canada, Singapore and Australia. But ordinary UPI payments and IPO-mandate UPI are not the same feature, and the latter remains patchy, broker-dependent, and frequently absent on NRI accounts even at banks that support general UPI.

So the honest, current picture as of 2026 is this: do not plan your application around UPI. Plan around net-banking ASBA. Log into your NRI bank's net-banking portal, find the ASBA or IPO section, select the open issue, enter your bid and demat details, and the bank blocks the amount directly in your NRE or NRO account. This route is reliable, available across essentially every bank that offers NRI accounts, and does not depend on whether your bank happens to have enabled the IPO-mandate UPI flow. If you have an ICICI or IDFC FIRST NRI account and your broker offers NRI UPI for IPOs, you can try it, but treat a working UPI mandate as a bonus, not the plan. Where a resident lazily relies on UPI, an NRI should default to ASBA and be pleasantly surprised if UPI happens to work.

There is one more reason this matters beyond convenience. UPI carries a per-transaction ceiling of Rs 5 lakh for IPO applications, which is comfortable for a retail bid (capped at Rs 2 lakh anyway) but irrelevant for an NRI applying in the non-institutional (HNI) category above Rs 2 lakh, where ASBA is the only sensible route regardless. If you are bidding large, you were always going through net-banking ASBA.

The NRI quota, and why your category matters more than the headline cap

The numbers people repeat are that NRIs can take up to 10% of an issue collectively, raisable to 24% with the requisite company approvals, and that any single NRI is limited to 5% of the issue. These caps are real but they almost never bind on a retail bid; an individual hitting 5% of a mainboard issue would be writing a cheque most NRIs are not writing. The number that actually governs your experience is the category you bid in.

Like residents, NRIs bid in one of two retail-relevant buckets. The Retail Individual Investor (RII) category covers applications up to Rs 2,00,000, where allotment in an oversubscribed issue is by lottery: above a threshold of oversubscription, every applicant either gets one minimum lot or nothing, and applying for more lots does not improve your odds of getting at least one. The Non-Institutional Investor (NII), often called the HNI category, covers applications above Rs 2,00,000, where allotment is proportionate to the amount bid. An NRI can apply in either, funded from NRE (repatriable) or NRO (non-repatriable) as decided above.

The decision that flows from this: if your goal is a listing-day flip and you are bidding small, applying for more than one lot in the retail category is usually wasted money in a heavily oversubscribed issue, because the lottery gives you at most one lot anyway. If you genuinely want a large position, the proportionate NII category is where size translates into shares, but it also locks up far more capital under ASBA for the bidding window and exposes you to the full price of a weak listing. Decide which game you are playing before you fund the bid.

The US and Canada wall is in the prospectus, not in Indian law

For NRIs in the United States and Canada this is the section that matters most, and the framing most blogs get slightly wrong. There is no Indian rule that says a US or Canada resident cannot apply to an IPO. The barrier is the issuer's own selling restriction, written to keep the offer from triggering registration obligations under US and Canadian securities law.

Most Indian mainboard IPOs are structured to be offered outside the US to non-US persons under Regulation S, with the prospectus carrying selling restrictions that exclude persons in the United States and, frequently, Canada. To stay on the right side of these restrictions, Indian brokers routinely disable IPO applications for NRIs whose KYC address is in the US or Canada. This is why the Toronto reader's application would not submit: not a bug, a deliberate block driven by the prospectus.

It is not absolute. Whether you can apply depends on the specific Red Herring Prospectus. Some issues explicitly permit applications from NRIs in the US and Canada, and a minority of brokers will enable the route for those issues. The only reliable way to know is to read the selling-restrictions section of the RHP before the issue opens, or ask your broker directly whether US and Canada applications are enabled for that particular issue. Do not generalise from one IPO to the next; the answer changes issue by issue. NRIs in the UK, UAE, Singapore, Australia and most other jurisdictions face no such blanket exclusion and can apply to essentially any issue that admits NRIs at all.

If you are a US or Canada NRI who keeps hitting this wall, the structural point is that the primary market is largely closed to you for mainboard issues, and your realistic equity access is the secondary market after listing, subject to your demat and PIS setup, plus the separate PFIC overlay that makes Indian mutual funds painful for US and Canada taxpayers, covered in the NRI mutual fund eligibility guide.

What you actually get taxed on when you flip the allotment

Most NRIs apply to IPOs for the listing pop, which means most NRI IPO gains are short-term, and the short-term number surprises people. Listed-equity gains run through Section 115AD for non-residents. If you sell within 12 months of allotment, which a listing-day flip always is, the gain is short-term and taxed at 20% (the rate rose from 15% for transfers on or after 23 July 2024), plus surcharge and cess. Hold beyond 12 months and the gain becomes long-term at 12.5% above the Rs 1.25 lakh annual exemption. The mechanics of 115AD, the surcharge cap, and the basic-exemption trap that hits NRIs specifically are all in capital gains tax on shares and mutual funds; the point here is just that the cheap 12.5% long-term rate does not apply to a flip.

The NRI-specific friction is TDS at source. When an NRI sells listed shares, tax is deducted before the proceeds hit your account, unlike a resident who simply settles up at return-filing time. On a listing-day sale through your broker, the deduction follows Section 195 read with 115AD on the gain at 20% plus surcharge and cess. The cash that lands in your account is already net of tax, which is exactly why filing an Indian return matters even on a small flip: TDS is deducted issue by issue without regard to your overall position, so if you also realised losses elsewhere, or your effective rate is lower, the only way to reconcile is to file and claim the refund. Check that the TDS shows in your Form 26AS and AIS before you assume it was done correctly.

Put real numbers on a typical retail flip. Take Anjali, a UK-resident NRI who applies repatriably from her NRE account in the retail category to a mainboard issue, bidding for one lot. The lot is Rs 14,820 at the IPO price (say 78 shares at Rs 190). The issue is oversubscribed, she wins the lottery, and one lot is allotted. On listing day the stock opens at Rs 247, a 30% pop, and she sells all 78 shares for Rs 19,266.

Her short-term gain is Rs 19,266 minus Rs 14,820 = Rs 4,446. Under Section 115AD that is taxed at 20%, so Rs 889.20 of tax, plus 4% cess of about Rs 35.57, a total of roughly Rs 925. Her net listing profit is about Rs 3,521. TDS is deducted at source on the gain, so the proceeds credited to her account already reflect it. Because she applied repatriably and sells through her repatriable setup, the net proceeds remain freely repatriable to the UK, where she will declare the gain and claim a foreign tax credit for the Indian tax under the capital gains guide's DTAA logic.

Now the counterfactual that changes the decision. Suppose Anjali had instead held the shares for 14 months and then sold, with the stock at the same Rs 247. Her gain of Rs 4,446 is now long-term under Section 115AD, and it falls entirely within the Rs 1.25 lakh annual long-term exemption, assuming she has no other long-term equity gains that year. Her Indian tax on the gain would be zero, against the roughly Rs 925 she paid by flipping on day one. The Rs 925 is the price of the 20% short-term rate, and for a small allotment it is the difference between a fully tax-free gain and a taxed one. That does not make holding right; the stock could give back the 30% pop. But it does mean the listing-day flip carries a 20% tax that a 12-month-plus hold can erase entirely within the annual exemption, and the maths is worth running before you reflexively sell on listing morning.

One more case shows the HNI trap. Take Imran, a UAE-resident NRI who bids in the NII (HNI) category for Rs 10,00,000 of a hot issue to get a proportionate allotment. The issue is oversubscribed 50 times in the NII bucket, so his proportionate allotment is roughly Rs 20,000 of shares, while the full Rs 10,00,000 was blocked under ASBA for the entire bidding and allotment window. His capital was frozen for days to win a small allotment, the unallotted Rs 9,80,000 is released only after allotment, and any listing gain is computed on the Rs 20,000 actually allotted. Because he is a genuine UAE tax resident, his listing gain may face zero Indian tax under the India-UAE treaty on shares with a TRC and Form 10F in place, the one bright spot, but the opportunity cost of blocking Rs 10 lakh to win Rs 20,000 of shares is the real story. For most NRIs chasing listing gains, the retail lottery is the more capital-efficient bet than oversubscribing the NII category.

Edge cases

Joint and second-holder applications. An IPO bid is made under the first holder's PAN and category. If you are a second holder on someone's account, you can still apply separately under your own PAN if you have your own demat and bank setup; you cannot stack a second application onto the same PAN to improve allotment odds.

The NRE account must actually hold the funds at bid time. ASBA blocks money already in the account; it does not pull from an inbound remittance in transit. If you are funding the bid from a fresh transfer from abroad, the money has to have landed and cleared in your NRE account before you apply, which for a same-week IPO means remitting several days early. NRIs routinely miss issues because the remittance settled a day after the issue closed.

Renouncing or applying in a rights issue is different from an IPO. This guide is about fresh IPOs. Rights issues have their own NRI rules and their own repatriation treatment, and the application mechanics through ASBA differ; do not assume the IPO process maps one-to-one.

SME IPOs and NRI eligibility. Some SME platform issues restrict or complicate NRI participation beyond the mainboard norm, and the lot sizes are far larger (often Rs 1 lakh-plus minimum), pushing you straight into the HNI dynamics above. Read the specific SME issue's terms; do not assume mainboard rules carry over.

Dubai and Gulf residents on the tax side. A genuine UAE tax resident can often face zero Indian tax even on a short-term listing gain on shares under the India-UAE treaty, with a Tax Residency Certificate and Form 10F. This is the single biggest tax advantage in NRI IPO investing and it is geography-specific; US, UK and Canada NRIs do not get it and pay the Indian rate, then claim a foreign tax credit at home.

The closing read

The honest read is that NRI IPO investing is entirely doable but the process is built for residents and you have to drive it manually. Three facts should shape how you approach it. First, the NRE/NRO and repatriable/non-repatriable choice is the whole game, made before you click apply, and getting the bank account, demat account and bid basis to line up is the one mistake that locks up your money for months. Second, plan for net-banking ASBA, not UPI, because the UPI-on-IPO flow remains unreliable on NRI accounts in 2026 regardless of what residents tell you. Third, read the RHP's selling restrictions if you are in the US or Canada, because the prospectus, not Indian law, is what blocks most of your applications.

So for most NRIs: apply through net-banking ASBA, decide repatriable (NRE) versus non-repatriable (NRO) based on whether you want the money to be able to leave India later, and stick to the retail lottery rather than blocking large sums in the NII category for a thin proportionate allotment. If you are flipping on listing day, accept the 20% short-term tax as the cost of the trade, file your return to reconcile the TDS, and remember that a 12-month-plus hold can erase the tax entirely within the Rs 1.25 lakh exemption. If you are a Gulf resident, get your TRC and Form 10F in place because your listing gains on shares may be tax-free in India. And if you are in the US or Canada, your realistic equity access is the secondary market after listing, not the primary market, for most mainboard issues. The exception worth paying for advice on is a large NII bid or an unusual cross-border structure; everything else here you can run yourself.

Related guides

• Buying Indian stocks under the Portfolio Investment Scheme (PIS)
• NRI demat account setup
• Capital gains tax for NRIs on shares and mutual funds
• NRE, NRO and FCNR accounts explained
• NRI mutual fund eligibility and the PFIC trap
• All Investments guides
• All Taxation guides
• All Banking guides

This guide is educational and general in nature. It is not individual investment or tax advice. IPO eligibility, repatriation treatment, UPI availability on NRI accounts, and the tax on listing gains depend on your residency, your bank and broker, the specific issue's prospectus, and rules that change over time, so confirm your specific position with your bank and a qualified chartered accountant before you apply or sell.